BJDX, PMI, SBFM Surge in Pre-Market Trading on June 2, 2026

Shares of BJDX, PMI, and SBFM spiked in pre-market activity on June 2, 2026, propelled by a wave of positive corporate announcements. BJDX climbed 15% after posting quarterly revenue that beat consensus estimates, citing robust enterprise demand for its cloud security platform. PMI advanced 8% following the U.S. Food and Drug Administration’s accelerated approval of its immunotherapy drug for lung cancer, a treatment analysts project could capture $500 million in peak annual sales. SBFM rallied 12% after disclosing a definitive takeover deal at $12.50 per share in cash, a 25% premium to its last close, representing a total equity value of $2.5 billion. The three stocks dominated pre-market volume charts, with combined turnover exceeding 3.5 million shares — roughly triple their respective 30-day averages.